Kam I - Search Results

1

The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation.

Zimmerman MA, Kelly MA, Campsen J, Mandell MS, Wachs M, Bak T, Skibba A, Lancaster B, Kam I. Zimmerman MA, et al. Among authors: kam i. Clin Transplant. 2010 Jul-Aug;24(4):E103-8. doi: 10.1111/j.1399-0012.2009.01179.x. Clin Transplant. 2010. PMID: 20030681

2

Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.

Trotter JF, Stolpman N, Wachs M, Bak T, Kugelmas M, Kam I, Everson GT. Trotter JF, et al. Among authors: kam i. Liver Transpl. 2002 Mar;8(3):212-8. doi: 10.1053/jlts.2002.31346. Liver Transpl. 2002. PMID: 11910565 Free article.

3

Adult-to-adult transplantation of the right hepatic lobe from a living donor.

Trotter JF, Wachs M, Everson GT, Kam I. Trotter JF, et al. Among authors: kam i. N Engl J Med. 2002 Apr 4;346(14):1074-82. doi: 10.1056/NEJMra011629. N Engl J Med. 2002. PMID: 11932476 Review. No abstract available.

4

Reduced use of intensive care after liver transplantation: influence of early extubation.

Mandell MS, Lezotte D, Kam I, Zamudio S. Mandell MS, et al. Among authors: kam i. Liver Transpl. 2002 Aug;8(8):676-81. doi: 10.1053/jlts.2002.34379. Liver Transpl. 2002. PMID: 12149759 Free article.

5

Reduced use of intensive care after liver transplantation: patient attributes that determine early transfer to surgical wards.

Mandell MS, Lezotte D, Kam I, Zamudio S. Mandell MS, et al. Among authors: kam i. Liver Transpl. 2002 Aug;8(8):682-7. doi: 10.1053/jlts.2002.34380. Liver Transpl. 2002. PMID: 12149760 Free article.

6

Comprehensive cost comparison of adult-adult right hepatic lobe living-donor liver transplantation with cadaveric transplantation.

Trotter JF, Mackenzie S, Wachs M, Bak T, Steinberg T, Polsky P, Kam I, Everson GT. Trotter JF, et al. Among authors: kam i. Transplantation. 2003 Feb 27;75(4):473-6. doi: 10.1097/01.TP.0000047310.04069.ED. Transplantation. 2003. PMID: 12605112

7

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications.

Dunkelberg JC, Trotter JF, Wachs M, Bak T, Kugelmas M, Steinberg T, Everson GT, Kam I. Dunkelberg JC, et al. Among authors: kam i. Liver Transpl. 2003 May;9(5):463-8. doi: 10.1053/jlts.2003.50079. Liver Transpl. 2003. PMID: 12740787 Free article. Clinical Trial.

8

Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.

Kugelmas M, Spiegelman P, Osgood MJ, Young DA, Trotter JF, Steinberg T, Wachs ME, Bak T, Kam I, Everson GT. Kugelmas M, et al. Among authors: kam i. Liver Transpl. 2003 Jul;9(7):727-32. doi: 10.1053/jlts.2003.50143. Liver Transpl. 2003. PMID: 12827560 Free article.

9

Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Hayashi PH, et al. Among authors: kam i. Liver Transpl. 2003 Jul;9(7):737-40. doi: 10.1053/jlts.2003.50122. Liver Transpl. 2003. PMID: 12827562 Free article.

10

Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.

Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT. Kugelmas M, et al. Among authors: kam i. Liver Transpl. 2003 Nov;9(11):1159-65. doi: 10.1053/jlts.2003.50233. Liver Transpl. 2003. PMID: 14586876 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters